WASHINGTON: The keenly-awaited full results from a UK trial of the steroid dexamethasone were published on Friday, confirming its life-saving benefits for Covid-19 patients on ventilators but suggesting it may cause harm if given too early. A total of 2,104 hospitalised patients were assigned to receive six milligram daily doses of the medicine for up to 10 days, and 4,321 to receive usual care, with the rate of deaths compared after 28 days. Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn Click here & earn ...
Comments
Post a Comment